Andrew Oxtoby is the founder of Kalaris Therapeutics (formerly AlloVir). Kalaris Therapeutics (formerly AlloVir) has raised $50M in total funding.
Andrew Oxtoby is the President and Chief Executive Officer of Kalaris Therapeutics, a biotechnology company. He has served as CEO and Director since 2024, and as President, CEO, and Director since 2025. Oxtoby is also a Non-Executive Director and previously served as a Director at the Damien Center.
Full founder directory · Investor directory · Company funding database · Fundraising library